Irtiza N. Sheikh, DO
Department of Pediatrics, Division of Pediatrics
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Pediatrics - Patient Care, Stem Cell Transplantation and Cellular Therapy Section, Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2017 | The University of North Texas Health Science Center, Fort Worth, Texas, US, Doctor of Osteopathic Medicine |
| 2013 | The University of Texas at Austin, Austin, Texas, US, Human Biology, Bachelor of Science |
Postgraduate Training
| 2022-2023 | Chief Fellowship, Pediatric Hematology-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2020-2022 | Clinical Fellowship, Pediatric Hematology/Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2017-2020 | Clinical Residency, Pediatrics, The University of Texas at Houston McGovern Medical School, Houston, Texas |
Licenses & Certifications
| 2025 | American Board of Pediatrics Hematology/Oncology |
| 2020 | The American Board of Pediatrics |
| 2020 | Texas Medical License |
Experience & Service
Administrative Appointments/Responsibilities
Associate Program Director, Department of Pediatrics -- Patient Care, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - Present
Extramural Institutional Committee Activities
President, Graduate Medical Education House Staff Senate, The University of Texas MD Anderson Cancer Center, 2022 - 2023
Treasurer, Graduate Medical Education House Staff Senate, The University of Texas MD Anderson Cancer Center, 2022 - 2023
Honors & Awards
| 2022 | A. Somberg Fellowship in Stem Cell Transplantation or Therapy Endowed Fellowship Research Award, The University of Texas MD Anderson Cancer Center |
| 2022 | Best Oral Presentation, Department of Pediatrics, The University of Texas MD Anderson Cancer Center |
| 2022 | Best Written Abstract, McGovern Medical School at the University of Texas, Department of Pediatrics Research Day |
| 2022 | Excellence in Pediatric Stem Cell Transplantation, Department of Pediatrics, The University of Texas MD Anderson Cancer Center |
| 2021 | Excellence in Pediatric Neuro-Oncology, Department of Pediatrics, The University of Texas MD Anderson Cancer Center |
| 2019 | Best Pediatric Resident Teaching Award, McGovern Medical School Medical |
Professional Memberships
Selected Presentations & Talks
International Presentations
- 2021. Development and Management of Cerebral Venous Sinus Thrombosis in a Female Patient with Hemophilia. Conference. Development and Management of Cerebral Venous Sinus Thrombosis in a Female Patient with Hemophilia. Philadelphia, US.
Grant & Contract Support
| Date: | 2023 - Present |
| Title: | Young Investigator Award |
| Funding Source: | American Society of Clinical Oncology, Conquer Cancer Grant |
| Role: | PI |
Selected Publications
Peer-Reviewed Articles
- Sheikh IN, Okeleji O, Afzal R, Bonfante E, Kodakandla M, Menon NM. Recurrent Nontraumatic Subgaleal Hematomas in a Pediatric Patient With Sickle Cell Disease. J Pediatr Hematol Oncol 46(3):e223-e226, 2024. e-Pub 2024. PMID: 38408160.
- Sheikh IN, Srivaths L, Li E, Steinberg-Shemer O, Mandel-Shorer N, Kenet G, Barg AA. Cerebral sinus venous thrombosis in children with inherited bleeding disorders: A case series. Pediatr Blood Cancer 69(10):e29902, 2022. e-Pub 2022. PMID: 35880957.
- Sheikh IN, Alqahtani S, Ragoonanan D, Tewari P, Petropoulos D, Mahadeo KM, Popat U, Shpall EJ, Khazal S. Post-Transplant Cyclophosphamide after Matched Sibling and Unrelated Donor Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Myeloid Leukemia. Int J Mol Sci 23(15), 2022. e-Pub 2022. PMID: 35955881.
- Sheikh I, Nunez C, McCall D, Roth M, Cuglievan B. Programmed cell death protein blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation in an adolescent patient. Pediatr Blood Cancer 69(3):e29390, 2022. e-Pub 2022. PMID: 35077016.
- Sheikh IN, Miller J, Shoberu B, Andersen CR, Wang J, Williams LA, Mahadeo KM, Robert R. Using the MDASI-Adolescent for Early Symptom Identification and Mitigation of Symptom Impact on Daily Living in Adolescent and Young Adult Stem Cell Transplant Patients. Children (Basel) 9(1), 2021. e-Pub 2021. PMID: 35053644.
Review Articles
- Sheikh IN, Elgehiny A, Ragoonanan D, Mahadeo KM, Nieto Y, Khazal S. Management of Aggressive Non-Hodgkin Lymphomas in the Pediatric, Adolescent, and Young Adult Population: An Adult vs. Pediatric Perspective. Cancers (Basel) 14(12), 2022. e-Pub 2022. PMID: 35740580.
- Sheikh IN, Roth M, Stavinoha PL. Prevalence of Sleep Disturbances in Pediatric Cancer Patients and Their Diagnosis and Management. Children (Basel) 8(12), 2021. e-Pub 2021. PMID: 34943294.
- Sheikh IN, Ragoonanan D, Franklin A, Srinivasan C, Zhao B, Petropoulos D, Mahadeo KM, Tewari P, Khazal SJ. Cardiac Relapse of Acute Lymphoblastic Leukemia Following Hematopoietic Stem Cell Transplantation: A Case Report and Review of Literature. Cancers (Basel) 13(22), 2021. e-Pub 2021. PMID: 34830969.
- Sheikh IN, Roberts WC. Relation of left ventricular free wall rupture and/or aneurysm with acute myocardial infarction in patients with aortic stenosis. Proc (Bayl Univ Med Cent) 30(2):161-162, 2017. e-Pub 2017. PMID: 28405066.
Abstracts
- Sheikh IN, Ragoonanan DR, Nunez C, Tewari P, Petropoulos D, Mahadeo KM, Neelapu S, Shpall E, Khazal S. Quantitative and Qualitative Immune Reconstitution Analysis in an Adolescent Patient with Refractory Primary Mediastinal Large B Cell Lymphoma After Axicabtagene Ciloleucel CD19 CAR T-Cell Therapy. Proceedings of the 2022 American Society for Transplantation and Cellular Therapy Tandem Meetings, 2022. e-Pub 2022.
- Sheikh IN, Ragoonanan DR, Tewari P, Petropoulos D, Mahadeo KM, Kebriaei P, Khazal S. Immune Reconstitution Following Tisagenlecleucel in Pediatric, Adolescent, and Young Adult (AYA) Patients with Relasped Refractory (R/R) B Acute Lymphoblastic Leukemia (B ALL). Proceedings of the 2022 American Society for Transplantation and Cellular Therapy Tandem Meetings, 2022. e-Pub 2022.
- Sheikh IN, Sarkar S, Jain T, Gibson A, Trabal G, Toepfer L, Bell D, McCall D, Nunez C, Roth M, Cuglievan B. Adolescent and Young Adults with Mixed Cellularity Classical Hodgkin Lymphoma: MD Anderson Cancer Center's 20-year Experience. Proceedings of the 2021 American Society of Pediatric Hematology/Oncology National Conference, 2021. e-Pub 2021.
- Sheikh IN, Sarkar S, Jain T, Gibson A, Trabal G, Toepfer L, Bell D, McCall D, Nunez C, Roth M, Cuglievan B. Adolescent and Young Adults with Mixed Cellularity Classical Hodgkin Lymphoma: MD Anderson Cancer Center's 20-year Experience. Proceedings of the 2021 American Society of Pediatric Hematology/Oncology National Conference, 2021. e-Pub 2021.
- Frost M, Elgehiny A, Truitt M, Sasser E, Brann L, Waseeemuddin M, Featherston S, Connors J, Petropoulos D, Tewari P, Ragoonanan D, Sheikh I. REFRACTORY INFANTILE CHORIOCARCINOMA CONDITIONED WITH GEMCITABINE, DOCETAXEL, MELPHALAN & CISPLATIN. ASPHO 2024.
- Alqahtani S, Sheikh I, Yin CC, Connors J, Ragoonanan D, Cuglievan B, McCall D, Gibson A, Nunez C, Roth M, Ohanian M, Borthakur G, Garcia M. AVAPRITINIB AND DECITABINE IN AN ADOLESCENT WITH CBF SM-AML 334. ASPHO 2024.
- Sheikh IN, Rav E, McCarthy A, Harden A, Itzep N, Andersen C, Moody K. THE USE OF TOPICAL ANALGESIC CREAM FOR LOCAL PAIN CONTROL IN PEDIATRIC ONCOLOGY PATIENTS. ASPHO 2024.
Letters to the Editor
- Sheikh, IN, Alqahtani, S, Okeleji, O, Brown, BD, Ragoonanan, D, Waseemuddin, M, Shoberu, B, Kawedia, J, Khazal, SJ, Connors, JS, Petropoulos, D, Tewari, P, Bonfim, C, Driscoll, TA, DePriest, BP, Mahadeo, KM. Pre-transplant immunosuppression in pediatric patients undergoing haploidentical stem cell transplant for sickle cell disease is associated with positive outcomes. Bone marrow transplantation 61: 241-244, 2026.
- Sheikh, IN, Uwaezuoke, D, Okeleji, O, Quesada, AE, Herzog, CE, Ragoonanan, D, Tewari, P, Petropoulos, D, McCall, DC, Nunez, CA, Roth, M, Cuglievan, B, Khazal, SJ. Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation. Pediatric Blood and Cancer 72, 2025.
- Sheikh IN, AlQahtani S, Yin CC, McCall D, Cuglievan B, Ragoonanan D, Connors JS, Gibson A, Nunez C, Roth M, Ohanian M, Borthakur G, Garcia MB. KIT-mutated pediatric core-binding factor systemic mastocytosis-acute myeloid leukemia treated with avapritinib and decitabine. Pediatr Blood Cancer 71: e30898, 2024.
Patient Reviews
CV information above last modified September 25, 2026